Oramed Pharmaceuticals
ORMP
#9104
Rank
A$0.14 B
Marketcap
$3.47
Share price
-2.78%
Change (1 day)
-12.42%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): A$36.67 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of A$11.78 Million, an increase over its 2022 earnings that were of -A$60.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$36.67 M211.2%
2023 A$11.78 M-119.45%
2022 -A$60.59 Million39.17%
2021 -A$43.54 Million73.93%
2020 -A$25.03 Million18.53%
2019 -A$21.12 Million-16.62%
2018 -A$25.33 Million38.32%
2017 -A$18.31 Million12.51%
2016 -A$16.28 Million25.01%
2015 -A$13.02 Million18.18%
2014 -A$11.02 Million39.72%
2013 -A$7.89 Million46.4%
2012 -A$5.39 Million128.32%
2011 -A$2.36 Million-51.47%
2010 -A$4.86 Million35.21%
2009 -A$3.6 Million
2007 -A$5.66 Million607.04%
2006 -A$0.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.84 Billion-2,147.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$31.32 B 76,757.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
A$13.13 B 32,128.38%๐Ÿ‡ซ๐Ÿ‡ท France
-A$16.06 Million-139.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-A$0.34 Billion-913.22%๐Ÿ‡บ๐Ÿ‡ธ USA